Gland Pharma Limited

NSE:GLAND.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

India

Market Cap

USD 3.65 B

Share Price

USD 22.17

Avg Daily Volume

347,786

Change (1 day)

-0.67%

Change (1 year)

-3.71%

Change (YTD)

6.65%

Gland Pharma Limited Accounts Payable for the year ending March 31, 2025: USD 96.00 M

Gland Pharma Limited Accounts Payable is USD 96.00 M for the year ending March 31, 2025, a -7.18% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Gland Pharma Limited Accounts Payable for the year ending March 31, 2024 was USD 103.43 M, a 44.73% change year over year.
Gland Pharma Limited Accounts Payable for the year ending March 31, 2023 was USD 71.46 M, a 17.23% change year over year.
Gland Pharma Limited Accounts Payable for the year ending March 31, 2022 was USD 60.96 M, a 12.61% change year over year.
Gland Pharma Limited Accounts Payable for the year ending March 31, 2021 was USD 54.13 M, a 63.76% change year over year.